Amanda Blackmon, D.O.
For hematologist Amanda Blackmon, D.O., the battle against blood cancers is a personal one. When she was young, she watched a close family member face leukemia and become a long-term survivor of the disease. This experience led to a unique perspective and passion to improve current treatments She aims to really understand each patient and their journey, listening carefully and helping them navigate their condition, to achieve the best possible outcomes. Her overall goals are to advocate for her patients and advance her field.
As a former chief fellow from UC Irvine, Dr. Blackmon was recognized over two consecutive years with UC Irvine’s Dr. Padmini Ayer Award for Excellence in Hematology/Oncology. She has presented research multiple times at conferences organized by SOHO, the American Society of Hematology and the National Comprehensive Cancer Network. Dr. Blackmon also served as an author for ASH News Daily which reports on the latest research in her field.
Duarte Cancer Center
Duarte, CA 91010
- 2015, Doctor of Osteopathic Medicine, Philadelphia College of Osteopathic Medicine, Philadelphia, PA
- 2010, Master of Science, Georgetown University School of Medicine, Washington D.C.
- 2009, Bachelor of Science, University of Maryland, College Park, MD
- 2022, Hematopoietic Stem Cell Transplantation and Cellular Therapy, City of Hope Comprehensive Cancer Center, Duarte, CA
- 2021, Hematology Oncology, University of California Irvine, Irvine, CA
- 2018, Residency, Internal Medicine, University of Pennsylvania (Pennsylvania Hospital), Philadelphia, PA
- 2018, Internal Medicine, University of Pennsylvania (Pennsylvania Hospital), Philadelphia, PA
- 2021, Dr. Padmini Ayer Award for Excellence in Hematology/Oncology
- 2021, 2021, Young Investigator Program Grant (YIP) for the SOHO
- 2020-2021, University of California Medical Center, Chief Fellow
- 2020, Dr. Padmini Ayer Award for Excellence in Hematology/Oncology
- 2012, Sigma Sigma Phi Honors
- 2017, Edward D. Viner, MD Teaching Award Nominee
-
Fazal, M., Wei, C., Chuy, K. L., Hussain, K., Gomez, S. E., Ba, S. S., Pietrasik, G., Yadav, N., Ghazizadeh, Z., Kapoor, R., Witteles, R. M., Blackmon, A., Wang, P. J., John, R. M., Narayan, S. M., Cheng, P., Rhee, J. W., & Baykaner, T. (2023). Tyrosine kinase inhibitor-associated ventricular arrhythmias: a case series and review of literature.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing,66(5), 1165–1175. https://doi.org/10.1007/s10840-022-01400-z
-
Yao, J. M., Otoukesh, S., Kim, H., Yang, D., Mokhtari, S., Samara, Y., Blackmon, A., Arslan, S., Agrawal, V., Pourhassan, H., Amanam, I., Ball, B., Koller, P., Salhotra, A., Becker, P., Curtin, P., Artz, A., Aldoss, I., Ali, H., Stewart, F., … Al Malki, M. M. (2023). Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.Transplantation and cellular therapy,29(8), 515.e1–515.e7. https://doi.org/10.1016/j.jtct.2023.05.008
-
Blackmon A, Amanam I, Al Malki M, Ali H, Otoukesh S. Chronic Myelomonocytic Leukemia (CMML): A systematic Review of Literature and Update. Journal of CancerScience and Clinical Therapeutics. 2022. 06.
-
Blackmon AL, Pinter-Brown L. Spotlight on Mogamulizumab-Kpkc for Use in Adultswith Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Ef cacy, Safety,and Patient Selection. Drug Des Devel Ther. 2020 Sep 16;14:3747-3754. doi:10.2147/DDDT.S185896. PMID: 32982179; PMCID: PMC7502391.
-
Blackmon A, O'Brien S. An update on acalabrutinib to treat chronic lymphocytic leukemia. Drugs Today (Barc). 2021 Jul;57(7):417-431.
-
Blackmon A, Aldoss I, Ball BJ. FLT3 Inhibitors as Maintenance Therapy after Allogeneic Stem-Cell Transplantation. Blood Lymphat Cancer. 2022 Sep 6;12:137-147. doi:10.2147/BLCTT.S281252. PMID: 36097605; PMCID: PMC9464008.
-
Merenstein D, Hu H, Wang C, Hamilton P, Blackmon M, Chen H, Calderone R, Li D. Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women. AIDS Res Hum Retroviruses. 2013 Jan;29(1):30-4. doi:10.1089/AID.2012.0269. Epub 2012 Nov 19. PMID: 23098053; PMCID: PMC3537294.
-
Hu H, Merenstein DJ, Wang C, Hamilton PR, Blackmon ML, Chen H, Calderone RA, Li D. Impact of eating probiotic yogurt on colonization by Candida species of the oral and vaginal mucosa in HIV-infected and HIV-uninfected women. Mycopathologia. 2013 Oct;176(3-4):175-81. doi: 10.1007/s11046-013-9678-4. Epub 2013 Aug 8. PMID:23925786; PMCID: PMC3903393.
-
Zhang L, She X, Merenstein D, Wang C, Hamilton P, Blackmon A, Hu H, Calderone R, Li D. Fluconazole Resistance Patterns in Candida Species that Colonize Women with HIV Infection. Curr Ther Res Clin Exp. 2014 Sep 28;76:84-9. doi:10.1016/j.curtheres.2014.07.002. PMID: 25352939; PMCID: PMC4209509.
-
Mendez Luque LF, Blackmon AL, Ramanathan G, Fleischman AG. Key Role of In ammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms. Curr Hematol Malig Rep. 2019 Jun;14(3):145-153. doi:10.1007/s11899-019-00508-w. PMID: 31119475; PMCID: PMC7746200.